BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32891875)

  • 1. EV-transported microRNAs of Schistosoma mansoni and Fasciola hepatica: Potential targets in definitive hosts.
    Ovchinnikov VY; Kashina EV; Mordvinov VA; Fromm B
    Infect Genet Evol; 2020 Nov; 85():104528. PubMed ID: 32891875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the presence and immunoregulatory functions of extracellular microRNAs in the trematode Fasciola hepatica.
    Fromm B; Ovchinnikov V; Høye E; Bernal D; Hackenberg M; Marcilla A
    Parasite Immunol; 2017 Feb; 39(2):. PubMed ID: 27809346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of
    Fontenla S; Langleib M; de la Torre-Escudero E; Domínguez MF; Robinson MW; Tort J
    Front Cell Infect Microbiol; 2021; 11():812141. PubMed ID: 35155272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection.
    Hoy AM; Lundie RJ; Ivens A; Quintana JF; Nausch N; Forster T; Jones F; Kabatereine NB; Dunne DW; Mutapi F; Macdonald AS; Buck AH
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2701. PubMed ID: 24587461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-specific miRNAs regulate gene expression associated with growth, development and parasite-host interaction during the intra-mammalian migration of the zoonotic helminth parasite Fasciola hepatica.
    Ricafrente A; Cwiklinski K; Nguyen H; Dalton JP; Tran N; Donnelly S
    BMC Genomics; 2022 Jun; 23(1):419. PubMed ID: 35659245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The revised microRNA complement of Fasciola hepatica reveals a plethora of overlooked microRNAs and evidence for enrichment of immuno-regulatory microRNAs in extracellular vesicles.
    Fromm B; Trelis M; Hackenberg M; Cantalapiedra F; Bernal D; Marcilla A
    Int J Parasitol; 2015 Sep; 45(11):697-702. PubMed ID: 26183562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Evaluation of the
    Ricafrente A; Nguyen H; Tran N; Donnelly S
    Front Immunol; 2020; 11():608686. PubMed ID: 33584684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the transcriptome of Fasciola hepatica - a key to fundamental and biotechnological discoveries for a neglected parasite.
    Young ND; Hall RS; Jex AR; Cantacessi C; Gasser RB
    Biotechnol Adv; 2010; 28(2):222-31. PubMed ID: 20006979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental Regulation and Functional Prediction of microRNAs in an Expanded
    Herron CM; O'Connor A; Robb E; McCammick E; Hill C; Marks NJ; Robinson MW; Maule AG; McVeigh P
    Front Cell Infect Microbiol; 2022; 12():811123. PubMed ID: 35223544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of MicroRNA Cargo of Extracellular Vesicles Isolated From the Plasma of
    Li S; Giri BR; Liu J; He X; Cai P; Jing Z; Cheng G
    Front Cell Infect Microbiol; 2022; 12():803242. PubMed ID: 35295754
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteases and their inhibitors involved in Schistosoma mansoni egg-host interaction revealed by comparative transcriptomics with Fasciola hepatica eggs.
    Peterkova K; Vorel J; Ilgova J; Ostasov P; Fajtova P; Konecny L; Chanova M; Kasny M; Horn M; Dvorak J
    Int J Parasitol; 2023 May; 53(5-6):253-263. PubMed ID: 36754342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative characterization of microRNAs from the liver flukes Fasciola gigantica and F. hepatica.
    Xu MJ; Ai L; Fu JH; Nisbet AJ; Liu QY; Chen MX; Zhou DH; Zhu XQ
    PLoS One; 2012; 7(12):e53387. PubMed ID: 23300925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pre-exposure to Fasciola hepatica or Schistosoma mansoni on challenge infection with Fasciola hepatica.
    el-Azazy OM; Schillhorn Van Veen TW
    Vet Parasitol; 1985 Jan; 17(2):173-6. PubMed ID: 3992871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miRnome of Fasciola hepatica juveniles endorses the existence of a reduced set of highly divergent micro RNAs in parasitic flatworms.
    Fontenla S; Dell'Oca N; Smircich P; Tort JF; Siles-Lucas M
    Int J Parasitol; 2015 Dec; 45(14):901-13. PubMed ID: 26432296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [RAPD variation in two trematode species (Fasciola hepatica and Dicrocoelium dendriticum) from a single cattle population].
    Morozova EV; Ryskov AP; Semenova SK
    Genetika; 2002 Aug; 38(8):1155-62. PubMed ID: 12244701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antigens of Paragonimus westermani, Schistosoma mansoni, and Fasciola hepatica adult worms. Evidence for the presence of cross-reactive antigens and for cross-protection to Schistosoma mansoni infection using antigens of Paragonimus westermani.
    Hillyer GV; Serrano AE
    Am J Trop Med Hyg; 1983 Mar; 32(2):350-8. PubMed ID: 6404188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
    Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepatica.
    Cancela M; Ruétalo N; Dell'Oca N; da Silva E; Smircich P; Rinaldi G; Roche L; Carmona C; Alvarez-Valín F; Zaha A; Tort JF
    BMC Genomics; 2010 Apr; 11():227. PubMed ID: 20374642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: possible implications for drug resistance.
    Beesley NJ; Williams DJ; Paterson S; Hodgkinson J
    Int J Parasitol; 2017 Jan; 47(1):11-20. PubMed ID: 27940066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.